Sanofi, Pfizer and NHS iPhone and Android Apps: Mobile Health Innovation

According a report published by ABI Research in 2011, the mobile health market is currently worth around Ј77million with 44million health apps downloaded last year. There have been a number of new innovative pharma apps released in the course of 2011.

 

In partnership with the US National Kidney Foundation, Pfizer, a real social media heavyweight in the industry, launched Manage CVD Risk in Reduced GFR app, designed for healthcare professionals to reduce the risk factors associated with cardiovascular disease (CVD).  

 

In 2011, IBGStar by Sanofi has become the first monitoring system for blood glucose that has been cleared by the FDA which directly connects to Apple's iPod touch and iPhone available in Germany, France, Switzerland, the Netherlands and Italy. For a quick overview of the app’s features, watch the video below.

Also released last year was MyAsthmaLog the NHS’s Android app designed to assist young people and children with asthma self-management by allowing them to construct an individual asthma plan and keep track of appointments and asthma attacks. For more detail, watch the video below.

Are you looking to develop a health app? Nitro Digital can help you! Call us on 0844 450 5545 or email us at info@nitro-digital.co.uk. To find out more about our work, check out our pharma marketing services.

Add new comment